Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study

Kemppinen, Anu; Soler-Cataluña, Juan José; Price, David; Miravitlles, Marc; Esquinas, Cristina; Barrecheguren, Miriam; Núñez, Alexa; Alcázar, Bernardino; García-Rivero, Juan Luis; Hueso, Karina; Román-Rodríguez, Miguel; Śliwiński, Paweł; Iwan, K.; Kolakowski, Jacek; Rhee, Chin Kook; Ahn, Esther; Tan, Jessica; Laperre, Therese; Leng, Karen Tan Li; Chia, Nicole Shuang Yu; How, Ong Thun; Shamsuddin, SyifaBinte; Gim, Sherine Lim Shu; Bee, Yap Chwee; Ya, Soh Rui; Tee, Augustine; Yan, Junjie; Hong, Samuel L.; Tan, W. H.; Carter, Victoria; Hardaker, Latife; McLaughlin, Andrew C.; Gouder, Caroline; Costello, Richard W.

doi:10.1016/j.arbr.2020.06.016

Cited by 2 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is supported by the use of CDS and the COPD control tool 56 (as described below in the PRO and PRI section) to achieve swift progress to optimum management. 57 Nonpharmacological intervention and consideration of the need for cardiovascular therapy are also an important part of QS 3. CDS tools will assist clinical decision-making by providing healthcare professionals with relevant patient information, from previously collected EMR, PRO, and PRI data, and considerations for pharmacological therapy at every consultation.…”

Section: Translation Of Quality Standards Into Clinical Practicementioning

confidence: 99%

“…Control status provides information on the risk of future exacerbations for the individual, and the tool is therefore used within CONQUEST to prompt early therapy review for an uncontrolled patient. 57 Collected and summarized PRO and PRI data are incorporated automatically into the EMR to achieve robust individual patient records that are correctly coded. The information obtained using these measures will be extracted along with EMR data to inform relevant quality indicators (described below), as well as providing valuable information for use in patient management.…”

Section: Patient-reported Outcomes (Pro) and Patient-reported Informa...mentioning

confidence: 99%

See 1 more Smart Citation

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Alves¹,

Pullen²,

Hurst³

et al. 2022

PROM

Self Cite

View full text Add to dashboard Cite

The COllaboration on QUality improvement initiative for achieving Excellence in STandards of COPD care (CONQUEST) aims to improve the quality of COPD care in primary care. The CONQUEST target population includes patients diagnosed with COPD, and those undiagnosed but with COPD-like exacerbations, who are at high but modifiable risk of COPD exacerbations, increased morbidity, and mortality. Timely diagnosis and optimized management to reduce these risks is vital. There is a need for a quality improvement program (QIP) that enables long-term improvement of patient clinical outcomes via integration of the program into routine clinical care. Core to the CONQUEST program is the adoption of four specifically designed, globally applicable, and expert-agreed quality standards (QS) for modifiable high-risk COPD patients. Translation of the QS into clinical practice, and implementation of the QIP, is guided by the CONQUEST global operational protocol provided to sites meeting the minimum healthcare system requirements. Initial analyses of current practices are conducted to generate baseline assessments of need within healthcare systems and sites looking to implement the QIP. Implementation is supported by the provision of CONQUEST resources and tools, such as clinical decision support, that promote prompt identification and treatment of patients. Utilization of electronic medical record (EMR) and patient-reported data are integral components of the QIP. Regular, automated collection and analysis of data, combined with a cyclical review of the implementation process, will be conducted for long-term, continuous improvement and health impact evaluation. The CONQUEST QIP will be an important resource in the identification and management of patients with modifiable high-risk COPD. Embedding the CONQUEST QS into routine clinical practice with regular evaluation and feedback will result in long-term quality of care improvement.

show abstract

Section: Translation Of Quality Standards Into Clinical Practicementioning

confidence: 99%

Section: Patient-reported Outcomes (Pro) and Patient-reported Informa...mentioning

confidence: 99%

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Alves¹,

Pullen²,

Hurst³

et al. 2022

PROM

Self Cite

View full text Add to dashboard Cite

show abstract

“…En el CAT el valor medio observado en la población incluida en el presente estudio fue de 14,6±6,9 similar al publicado por Marc Miravitlles et al 151 que observan un valor medio de 14,4±8,6 y muy próximo al observado por Raúl Galera et al 152 que encuentran puntuaciones de 16±9 y de 11±7 en pacientes EPOC con y sin hiperinsuflación dinámica, o los publicados por María Koreny et al 153 , que en un estudio para analizar los patrones de progresión de la actividad física en pacientes con EPOC observa valores de 12.9±7.6. En nuestro estudio se observa como la puntuación en el CAT aumenta a medida que lo hace el grado de obstrucción de la vía aérea, aunque ya hemos señalado que las diferencias no alcanzan la significación estadística.…”

Section: 4-test Hads Global En Pacientes Con Edad ≥ 65 Añosunclassified

Prevalencia de ansiedad y depresión en pacientes EPOC

Otero¹

View full text Add to dashboard Cite

show abstract

Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study

Abstract: The study was designed and coordinated by the Respiratory Effectiveness Group (REG; www.effectivenessevaluation.org; Cambridge, UK) and delivered by Optimum Patient Care (OPC; www.optimumpatientcare.org). Funding: The study was funded by an unrestricted grant from Novartis AG.

Cited by 2 publications

References 20 publications

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients

Prevalencia de ansiedad y depresión en pacientes EPOC

Contact Info

Product

Resources

About